Shopping Cart 0
Cart Subtotal
USD 0

Gulf Pharmaceutical Industries PSC (JULPHAR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Gulf Pharmaceutical Industries PSC (Julphar) is a pharmaceutical company that manufactures and distributes medicines in the Middle East and North Africa (MENA) region. The company's product portfolio consists of antibiotics, antiseptics, wound care and biotechnology, women care, adult primary care, pediatric primary care, cardiopulmonary care, gastro care and pain management and consumer care products. The company has manufacturing facilities in Ethiopia, Bangladesh and Saudi Arabia. Julphar has offices in Asia, Middle East and Africa and is headquartered in Digdaga, Ras Al Khaimah, the UAE.

Gulf Pharmaceutical Industries PSC (JULPHAR)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Gulf Pharmaceutical Industries PSC, Medical Devices Deals, 2012 to YTD 2018 10

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

EMD Millipore Enters Into Co-Marketing Agreement With Julphar Diabetes For Recombinant Human Insulin 12

MSD Enters Into Distribution Agreement With Julphar 13

Licensing Agreements 14

Gulf Pharmaceutical Industries (Julphar) Enters into Licensing Agreement with Merck 14

Gulf Pharma Enters into Licensing Agreement with MSD 15

BMG Pharma Enters Into Licensing Agreement With Julphar For Ginoxil 16

Acquisition 17

Julphar Acquires 77.5% Stake in RAK Pharma for USD9.5 Million 17

Gulf Pharmaceutical Industries PSC-Key Competitors 18

Gulf Pharmaceutical Industries PSC-Key Employees 19

Gulf Pharmaceutical Industries PSC-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Joint Venture 21

Recent Developments 22

Financial Announcements 22

Aug 19, 2018: Julphar Posts Solid First Half Results 22

May 17, 2018: Julphar Announces Q1 Results 23

Mar 06, 2018: Julphar Targets Double-Digit Growth in 2018 24

Nov 19, 2017: Julphar announces Q3 2017 results 25

Corporate Communications 26

Aug 27, 2017: Julphar's Board of Directors appoints Jerome Carle as General Manager 26

Jan 29, 2017: Julphar CEO leaves the company after 8 years of service 27

Jan 09, 2017: Julphar appoints new CFO 28

Product News 29

Dec 18, 2017: Julphar Marks Entry into New Sector at First Men's Health Congress 29

Appendix 30

Methodology 30

About GlobalData 30

Contact Us 30

Disclaimer 30


List Of Figure

List of Figures

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Gulf Pharmaceutical Industries PSC, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Gulf Pharmaceutical Industries PSC, Deals By Therapy Area, 2012 to YTD 2018 8

Gulf Pharmaceutical Industries PSC, Medical Devices Deals, 2012 to YTD 2018 10

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

EMD Millipore Enters Into Co-Marketing Agreement With Julphar Diabetes For Recombinant Human Insulin 12

MSD Enters Into Distribution Agreement With Julphar 13

Gulf Pharmaceutical Industries (Julphar) Enters into Licensing Agreement with Merck 14

Gulf Pharma Enters into Licensing Agreement with MSD 15

BMG Pharma Enters Into Licensing Agreement With Julphar For Ginoxil 16

Julphar Acquires 77.5% Stake in RAK Pharma for USD9.5 Million 17

Gulf Pharmaceutical Industries PSC, Key Competitors 18

Gulf Pharmaceutical Industries PSC, Key Employees 19

Gulf Pharmaceutical Industries PSC, Subsidiaries 20

Gulf Pharmaceutical Industries PSC, Joint Venture 21

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Gulf Pharmaceutical Industries PSC, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Gulf Pharmaceutical Industries PSC (Julphar) is a pharmaceutical company that manufactures and distributes medicines in the Middle East and North Africa (MENA) region. The company's product portfolio consists of antibiotics, antiseptics, wound care and biotechnology, women care, adult primary care, pediatric primary care, cardiopulmonary care, gastro care and pain management and consumer care products. The company has manufacturing facilities in Ethiopia, Bangladesh and Saudi Arabia. Julphar has offices in Asia, Middle East and Africa and is headquartered in Digdaga, Ras Al Khaimah, the UAE.

Gulf Pharmaceutical Industries PSC (JULPHAR)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Gulf Pharmaceutical Industries PSC, Medical Devices Deals, 2012 to YTD 2018 10

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

EMD Millipore Enters Into Co-Marketing Agreement With Julphar Diabetes For Recombinant Human Insulin 12

MSD Enters Into Distribution Agreement With Julphar 13

Licensing Agreements 14

Gulf Pharmaceutical Industries (Julphar) Enters into Licensing Agreement with Merck 14

Gulf Pharma Enters into Licensing Agreement with MSD 15

BMG Pharma Enters Into Licensing Agreement With Julphar For Ginoxil 16

Acquisition 17

Julphar Acquires 77.5% Stake in RAK Pharma for USD9.5 Million 17

Gulf Pharmaceutical Industries PSC-Key Competitors 18

Gulf Pharmaceutical Industries PSC-Key Employees 19

Gulf Pharmaceutical Industries PSC-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Joint Venture 21

Recent Developments 22

Financial Announcements 22

Aug 19, 2018: Julphar Posts Solid First Half Results 22

May 17, 2018: Julphar Announces Q1 Results 23

Mar 06, 2018: Julphar Targets Double-Digit Growth in 2018 24

Nov 19, 2017: Julphar announces Q3 2017 results 25

Corporate Communications 26

Aug 27, 2017: Julphar's Board of Directors appoints Jerome Carle as General Manager 26

Jan 29, 2017: Julphar CEO leaves the company after 8 years of service 27

Jan 09, 2017: Julphar appoints new CFO 28

Product News 29

Dec 18, 2017: Julphar Marks Entry into New Sector at First Men's Health Congress 29

Appendix 30

Methodology 30

About GlobalData 30

Contact Us 30

Disclaimer 30


List Of Figure

List of Figures

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Gulf Pharmaceutical Industries PSC, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Gulf Pharmaceutical Industries PSC, Deals By Therapy Area, 2012 to YTD 2018 8

Gulf Pharmaceutical Industries PSC, Medical Devices Deals, 2012 to YTD 2018 10

Gulf Pharmaceutical Industries PSC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

EMD Millipore Enters Into Co-Marketing Agreement With Julphar Diabetes For Recombinant Human Insulin 12

MSD Enters Into Distribution Agreement With Julphar 13

Gulf Pharmaceutical Industries (Julphar) Enters into Licensing Agreement with Merck 14

Gulf Pharma Enters into Licensing Agreement with MSD 15

BMG Pharma Enters Into Licensing Agreement With Julphar For Ginoxil 16

Julphar Acquires 77.5% Stake in RAK Pharma for USD9.5 Million 17

Gulf Pharmaceutical Industries PSC, Key Competitors 18

Gulf Pharmaceutical Industries PSC, Key Employees 19

Gulf Pharmaceutical Industries PSC, Subsidiaries 20

Gulf Pharmaceutical Industries PSC, Joint Venture 21

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Gulf Pharmaceutical Industries PSC, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.